• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过竞争性抗原淘选筛选新型gp41特异性HIV-1中和人抗体。

Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning.

作者信息

Zhang Mei-Yun, Choudhry Vidita, Sidorov Igor A, Tenev Vladimir, Vu Bang K, Choudhary Anil, Lu Hong, Stiegler Gabriela M, Katinger Hermann W D, Jiang Shibo, Broder Christopher C, Dimitrov Dimiter S

机构信息

Protein Interactions Group, CCRNP, CCR, NCI-Frederick, NIH, Frederick, Maryland 21702, USA.

出版信息

J Immunol Methods. 2006 Dec 20;317(1-2):21-30. doi: 10.1016/j.jim.2006.09.016. Epub 2006 Oct 16.

DOI:10.1016/j.jim.2006.09.016
PMID:17078964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1805821/
Abstract

The HIV envelope glycoprotein (Env) is composed of two non-covalently associated subunits: gp120 and gp41. Panning of phage-displayed antibody libraries against Env-based antigens has resulted mostly in selection of anti-gp120 antibodies. Native gp41 in the absence of gp120 is unstable. The use of gp41 fragments as antigens has resulted in selection of antibodies with only relatively modest neutralizing activity. To enhance selection of antibodies specific for gp41 in the context of the whole Env we developed a methodology termed competitive antigen panning (CAP). Using CAP, we identified a novel gp41-specific human monoclonal antibody (hmAb), m48, from an immune library derived from long-term nonprogressors with high titers of broadly cross-reactive neutralizing antibodies (bcnAbs). Selection of m48 was only successful using CAP and not through the conventional pre-incubation methodology. In assays based on spreading infection in peripheral blood mononuclear cells (PBMCs) m48 neutralized a panel of HIV-1 primary isolates from different clades more potently than the well-characterized broadly cross-reactive HIV-1-neutralizing antibodies IgG1 4E10 and Fab Z13. These results may have implications for the selection of novel gp41-specific bcnAbs and other antibodies, and for the development of HIV-1 inhibitors and vaccine immunogens.

摘要

人类免疫缺陷病毒包膜糖蛋白(Env)由两个非共价结合的亚基组成:gp120和gp41。针对基于Env的抗原进行噬菌体展示抗体文库淘选,大多筛选出了抗gp120抗体。在没有gp120的情况下,天然gp41不稳定。使用gp41片段作为抗原,只能筛选出中和活性相对较低的抗体。为了在完整Env背景下增强对gp41特异性抗体的筛选,我们开发了一种称为竞争性抗原淘选(CAP)的方法。利用CAP,我们从具有高滴度广泛交叉反应性中和抗体(bcnAbs)的长期非进展者来源的免疫文库中,鉴定出一种新型的gp41特异性人单克隆抗体(hmAb)m48。只有使用CAP才能成功筛选出m48,而通过传统的预孵育方法则无法成功筛选。在外周血单核细胞(PBMC)中基于传播感染的检测中,m48比特征明确的广泛交叉反应性HIV-1中和抗体IgG1 4E10和Fab Z13更有效地中和了一组来自不同分支的HIV-1原代分离株。这些结果可能对新型gp41特异性bcnAbs和其他抗体的筛选,以及对HIV-1抑制剂和疫苗免疫原的开发具有启示意义。

相似文献

1
Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning.通过竞争性抗原淘选筛选新型gp41特异性HIV-1中和人抗体。
J Immunol Methods. 2006 Dec 20;317(1-2):21-30. doi: 10.1016/j.jim.2006.09.016. Epub 2006 Oct 16.
2
Competitive antigen panning for selection of HIV-1 neutralizing human monoclonal antibodies specific for gp41.用于筛选针对gp41的HIV-1中和人单克隆抗体的竞争性抗原淘选
Methods Mol Biol. 2009;525:175-86, xv. doi: 10.1007/978-1-59745-554-1_9.
3
Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.通过筛选免疫人噬菌体文库以对抗从具有广泛HIV-1中和抗体的患者(R2)分离出的包膜糖蛋白(gp140)而选择的交叉反应性HIV-1中和单克隆抗体。
Virology. 2007 Jun 20;363(1):79-90. doi: 10.1016/j.virol.2007.01.015. Epub 2007 Feb 15.
4
Novel approaches for identification of broadly cross-reactive HIV-1 neutralizing human monoclonal antibodies and improvement of their potency.鉴定具有广泛交叉反应性的HIV-1中和人单克隆抗体及其效力改进的新方法。
Curr Pharm Des. 2007;13(2):203-12. doi: 10.2174/138161207779313669.
5
Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens.交叉反应性1型人类免疫缺陷病毒中和性人单克隆抗体,该抗体识别gp41上的一个新构象表位,且对自身抗原无反应性。
J Virol. 2008 Jul;82(14):6869-79. doi: 10.1128/JVI.00033-08. Epub 2008 May 14.
6
Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41.鉴定并描述一种广谱中和性 HIV-1 人源单克隆抗体,该抗体能与 gp120 和 gp41 结合。
PLoS One. 2012;7(9):e44241. doi: 10.1371/journal.pone.0044241. Epub 2012 Sep 10.
7
Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody.一种新型交叉反应性1型人类免疫缺陷病毒中和性人单克隆抗体的鉴定与表征
J Virol. 2004 Sep;78(17):9233-42. doi: 10.1128/JVI.78.17.9233-9242.2004.
8
HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.1型人类免疫缺陷病毒包膜前体的切割状态影响中和性和非中和性gp41抗体的识别。
AIDS Res Hum Retroviruses. 2011 Aug;27(8):877-87. doi: 10.1089/AID.2010.0281. Epub 2011 Jan 19.
9
Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.一种通过病毒逃逸导致膜近端外部区域(MPER)暴露的新型HIV-1 gp120-gp41界面抗体的结构与识别
PLoS Pathog. 2017 Jan 11;13(1):e1006074. doi: 10.1371/journal.ppat.1006074. eCollection 2017 Jan.
10
A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.一种针对1型人类免疫缺陷病毒gp41上新表位的强效跨亚型中和人单克隆抗体。
AIDS Res Hum Retroviruses. 2001 Dec 10;17(18):1757-65. doi: 10.1089/08892220152741450.

引用本文的文献

1
Epitope-specific affinity maturation improved stability of potent protease inhibitory antibodies.表位特异性亲和力成熟提高了强效蛋白酶抑制抗体的稳定性。
Biotechnol Bioeng. 2018 Nov;115(11):2673-2682. doi: 10.1002/bit.26814. Epub 2018 Sep 15.
2
Brief introduction of current technologies in isolation of broadly neutralizing HIV-1 antibodies.广泛中和性HIV-1抗体分离的当前技术简介
Virus Res. 2018 Jan 2;243:75-82. doi: 10.1016/j.virusres.2017.10.011. Epub 2017 Oct 16.
3
Impaired Immunogenicity of Meningococcal Neisserial Surface Protein A in Human Complement Factor H Transgenic Mice.人补体因子H转基因小鼠中脑膜炎奈瑟菌表面蛋白A的免疫原性受损
Infect Immun. 2015 Nov 23;84(2):452-8. doi: 10.1128/IAI.01267-15. Print 2016 Feb.
4
Profiling the IgOme: meeting the challenge.IgOme 分析:迎接挑战。
FEBS Lett. 2014 Jan 21;588(2):318-25. doi: 10.1016/j.febslet.2013.11.005. Epub 2013 Nov 12.
5
Highly efficient selection of epitope specific antibody through competitive yeast display library sorting.通过竞争性酵母展示文库分选技术高效选择表位特异性抗体。
MAbs. 2013 Jul-Aug;5(4):533-9. doi: 10.4161/mabs.25211. Epub 2013 May 29.
6
Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41.鉴定并描述一种广谱中和性 HIV-1 人源单克隆抗体,该抗体能与 gp120 和 gp41 结合。
PLoS One. 2012;7(9):e44241. doi: 10.1371/journal.pone.0044241. Epub 2012 Sep 10.
7
Phages and HIV-1: from display to interplay.噬菌体与人类免疫缺陷病毒1型:从展示到相互作用
Int J Mol Sci. 2012;13(4):4727-4794. doi: 10.3390/ijms13044727. Epub 2012 Apr 13.
8
Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies.HIV-1 中和抗体的交叉反应性成熟途径。
Viruses. 2009 Dec;1(3):802-17. doi: 10.3390/v1030802. Epub 2009 Nov 6.
9
Monoclonal antibody-based candidate therapeutics against HIV type 1.基于单克隆抗体的抗1型人类免疫缺陷病毒候选疗法。
AIDS Res Hum Retroviruses. 2012 May;28(5):425-34. doi: 10.1089/AID.2011.0226. Epub 2011 Sep 23.
10
Identification of a gp41 core-binding molecule with homologous sequence of human TNNI3K-like protein as a novel human immunodeficiency virus type 1 entry inhibitor.鉴定一种 gp41 核心结合分子,其与人 TNNI3K 样蛋白具有同源序列,作为一种新型人类免疫缺陷病毒 1 型进入抑制剂。
J Virol. 2010 Sep;84(18):9359-68. doi: 10.1128/JVI.00644-10. Epub 2010 Jun 30.

本文引用的文献

1
Characterization and HIV-1 fusion inhibitory properties of monoclonal Fabs obtained from a human non-immune phage library selected against diverse epitopes of the ectodomain of HIV-1 gp41.从针对HIV-1 gp41胞外域不同表位筛选的人非免疫噬菌体文库中获得的单克隆Fab片段的特性及HIV-1融合抑制特性
J Mol Biol. 2005 Nov 11;353(5):945-51. doi: 10.1016/j.jmb.2005.09.044. Epub 2005 Sep 30.
2
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope.一种人源单克隆抗体通过结合关键的gp41表位来中和多种HIV-1分离株。
Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14759-64. doi: 10.1073/pnas.0506927102. Epub 2005 Oct 3.
3
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies.一组抗1型人类免疫缺陷病毒单克隆抗体的全面跨谱系中和分析
J Virol. 2004 Dec;78(23):13232-52. doi: 10.1128/JVI.78.23.13232-13252.2004.
4
N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion.N-取代吡咯衍生物作为新型1型人类免疫缺陷病毒进入抑制剂,可干扰gp41六螺旋束的形成并阻断病毒融合。
Antimicrob Agents Chemother. 2004 Nov;48(11):4349-59. doi: 10.1128/AAC.48.11.4349-4359.2004.
5
Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody.一种新型交叉反应性1型人类免疫缺陷病毒中和性人单克隆抗体的鉴定与表征
J Virol. 2004 Sep;78(17):9233-42. doi: 10.1128/JVI.78.17.9233-9242.2004.
6
Prospects for an AIDS vaccine: three big questions, no easy answers.艾滋病疫苗的前景:三大问题,答案不易
Lancet Infect Dis. 2004 Jul;4(7):397-413. doi: 10.1016/S1473-3099(04)01056-4.
7
Identification of a novel CD4i human monoclonal antibody Fab that neutralizes HIV-1 primary isolates from different clades.一种新型CD4i人源单克隆抗体Fab的鉴定,该抗体可中和来自不同分支的HIV-1原始分离株。
Antiviral Res. 2004 Mar;61(3):161-4. doi: 10.1016/j.antiviral.2003.09.009.
8
Virus entry: molecular mechanisms and biomedical applications.病毒进入:分子机制与生物医学应用
Nat Rev Microbiol. 2004 Feb;2(2):109-22. doi: 10.1038/nrmicro817.
9
Identifying epitopes of HIV-1 that induce protective antibodies.鉴定可诱导保护性抗体的HIV-1表位。
Nat Rev Immunol. 2004 Mar;4(3):199-210. doi: 10.1038/nri1307.
10
Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library.通过噬菌体展示文库的连续抗原淘选筛选出的具有广泛交叉反应性的HIV中和人单克隆抗体Fab
J Immunol Methods. 2003 Dec;283(1-2):17-25. doi: 10.1016/j.jim.2003.07.003.